Atlas Trials

Targeted Therapy

30 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Targeted Therapy

RecordFirmDate
Niraparib Plus Anlotinib for Recurrent Ovarian Cancer (NCT05311579)Lei Li2022-03-27
Donafenib for Recurrent Cervical Cancer (NCT05310331)Lei Li2022-03-27
Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC (NCT06818097)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2021-10-01
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude (NCT05063643)Affiliated Hospital of Qinghai University2021-10-01
First-line Chemotherapy for Recurrent Cervical Cancer (NCT04188847)Lei Li2019-12-06
SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC (NCT06889649)Peking University First Hospital2019-01-01
An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal (NCT05225844)Harbin Medical University2019-01-01
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer (NCT04656249)Peking Union Medical College Hospital2018-01-01
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System (NCT03185988)Shen Lin2017-07-01
AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies (NCT02504346)Oslo University Hospital2015-08-01
Neoadjuvant Treatment Modalities in Esophageal Cancer (NCT04821843)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2002-01-01

Track Targeted Therapy automatically

Every clearance here is in the API, with alerts when new ones post.